COMP was reported to promote fibrosis in multiple organs, such as the skin, lung, and liver, and also contributes to the development of tumors, including colon cancer, breast cancer, and hepatocellular carcinoma (Li et al., 2018). This evidence concerns the gene COMP and colonic neoplasm.